ADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.83 million - TENX News | RalliesADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.83 million
T
TENX• ADAR1 raises indirect Tenax stake
- ADAR1 Capital Management raised its indirect stake in Tenax Therapeutics to 4,853,818 common shares.
- Daniel Schneeberger, manager, reported the position as indirectly held through private investment funds managed by ADAR1.
- Purchases were reported at weighted-average prices of $1.78, $1.77, and $1.75 per share.
JNJ
•
